For the first time in human’s clinical trial, women with either breast or female internal reproductive organ tumors were injected intravenously with Microbubbles capable of binding and recognize the cancer. This is the technique which is secure and susceptible.
Medical microbubbles are spheres of phospholipids, an equivalent material that produces up the membranes of living cells. The bubbles square measure 1 to 4 microns in diameter which is slightly smaller than a red blood corpuscle and crammed with a harmless mixture of perfluorobutane and element gas.
The microbubbles will be binded to a receptor by KDR which is found on the tumor blood vessels of cancer, however not in healthy tissue. A noncancerous cell doesn’t have such receptors. And since benign breast and female internal reproductive organ tumors sometimes lack KDR, the labeled microbubbles which are usually known as MBKDR, passes through them such that the bubbles stay hooked up to the tumor cells for much time and allows the clinicians to go on with the test using ultrasound technology.
The KDR microbubbles strengthen and recover the diagnoses and avoid the unnecessary surgeries in ladies suspected of getting breast or female internal reproductive organ cancer.